Advertisement Vetter Development Service - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
close icon

Vetter Pharma International

Aseptically Prefilled Syringe Systems, Cartridges and Vials

Vetter Development Service

Vetter Pharma International

It is essential that a substance and its delivery system are optimally compatible. Biotechnology drugs, in particular, contain highly sensitive active ingredients that can interact with the drug-delivery system. Other considerations include a drug's sensitivity to oxygen or to the silicone that coats the inside of a syringe to lubricate the plunger.

Vetter Development Service specialises in taking complex compounds from preclinical development through market launch. In close collaboration with its customers, Vetter selects:

  • The drug-delivery system that matches the requirements of the drug in development
  • Appropriate processes, such as lyophilisation (freeze-drying) for unstable products
  • Suitable transport magazines and secondary packaging components
  • Special inspection devices and methods

During manufacture, state-of-the-art technology and methods minimise loss of active ingredient. To help prevent surprises at market production, commercial manufacturing processes are replicated in early-stage laboratories. At phase III, products are transferred to Vetter Commercial Manufacturing for large-scale filling.

Vetter Development Service provides:

  • Primary and secondary packaging development
  • Process development
  • Clinical manufacturing
  • Pharmaceutical analysis and stability storage
  • Regulatory affairs services
  • Transfer to Vetter Commercial Manufacturing
Quick Contact Vetter Development Service